July 7, 2020 / 12:17 PM / a month ago

BRIEF-Diffusion Pharmaceuticals Files IND For International Phase 1B/2B Covid-19 Clinical Program With TSC

July 7 (Reuters) - Diffusion Pharmaceuticals Inc:

* DIFFUSION PHARMACEUTICALS FILES IND FOR INTERNATIONAL PHASE 1B/2B COVID-19 CLINICAL PROGRAM WITH TSC

* DIFFUSION PHARMACEUTICALS INC - PHASE 1B DOSING EXPECTED TO BEGIN THIS MONTH

* DIFFUSION PHARMACEUTICALS INC - DATA READ-OUT EXPECTED LATER THIS QUARTER

* DIFFUSION PHARMACEUTICALS INC - PHASE 1B DOSING EXPECTED TO BEGIN THIS MONTH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below